Precision Genome Engineering Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Precision Genome Engineering General Information

Description

Developer of gene therapies for severe genetic disorders. The company uses stem cells harvested from patient's bone marrow into which a healthy version of the disease causing gene is inserted.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 454 North 34th Street
  • Seattle, WA 98103
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision Genome Engineering Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Precision Genome Engineering‘s full profile, request access.

Request a free trial

Precision Genome Engineering Executive Team (3)

Name Title Board Seat Contact Info
Laurie Beitz MD Chief Operating Officer
Barry Stoddard Ph.D Co-Founder & Member of Scientific Advisory Board
David Baker Ph.D Co-Founder
To view Precision Genome Engineering’s complete executive team members history, request access »